Alerzin

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Alerzin

Alerzin is a medication designed for the systemic management of allergic symptoms, defined by its active chemical composition and precise pharmacological action.


Quick Facts: Alerzin

Property Description
Active Ingredient Cetirizine Hydrochloride
Form Film-coated tablets, oral drops, and oral solution (syrup)
Pharmacological Class Second-generation antihistamine (Selective peripheral H(1) receptor antagonist)
Common Use Management of allergic conditions and hypersensitivity reactions
Origin Synthetic compound (Piperazine derivative)

Definition and Pharmacological Classification

The core component of Alerzin is the synthetic active ingredient, Cetirizine Hydrochloride. This substance positions the drug as a second-generation antihistamine. This designation informs patients that the drug has been developed to effectively target histamine activity with a reduced potential for causing drowsiness compared to older agents. This mechanism is intended for providing reliable relief in conditions exacerbated by histamine release.

Cetirizine Hydrochloride is a piperazine derivative and a single active ingredient product. The chemical structure functions as a selective peripheral H(1) receptor antagonist. This specific classification confirms the drug's specialized role in providing targeted relief for immune-mediated reactions, distinguishing it from first-generation agents like hydroxyzine, from which it is chemically derived.

General Purpose and Available Forms

Alerzin is intended for systemic use to address the symptoms arising from various allergic conditions, such as when the body reacts excessively to seasonal irritants. Its primary purpose involves blocking the action of histamine, the natural chemical responsible for mediating allergy symptoms.

The medicine's identity includes its diverse dosage forms: film-coated tablets, oral drops, and oral solution (syrup). These forms contain the same active Cetirizine Hydrochloride base, and the availability of a liquid oral solution is a differentiating feature that makes the product suitable for patient groups who require flexible or smaller doses. The overarching general benefit is the dependable suppression of the uncomfortable physical symptoms that are hallmarks of the body's allergic overreaction.

What side effects are possible with Alerzin?

The safety profile of Alerzin (Cetirizine Hydrochloride) is documented through official classifications and frequency standards established by government regulatory agencies. The most frequently observed adverse reactions are categorized as Common, occurring in up to 1 in 10 individuals, and primarily affect the nervous and gastrointestinal systems. These include somnolence (drowsiness), headache, fatigue, dry mouth, and nausea.

Less frequent adverse effects are classified as Uncommon (up to 1 in 100 people), such as pruritus (itching) and abdominal pain. Rare and Very Rare events are also documented and cover more clinically significant reactions. Rare events include serious conditions like hypersensitivity reactions and hepatitis. Very Rare events include anaphylactic shock and glomerulonephritis, while reactions like suicidal ideation and urinary retention have a Not Known frequency.

Population and Time-Related Safety

Specific safety considerations are necessary for certain patient groups. Individuals with moderate to severe renal impairment require a specific dose adjustment, as the drug is primarily eliminated via the kidneys. Official labeling also includes notes on effects related to drug exposure, stating that somnolence is a dose-related effect and that pruritus or urticaria have been reported upon the discontinuation of long-term treatment. The safety profile is defined by these classifications, which delineate common, expected side effects from documented rare, serious risks.

Overdose and Emergency Response

Overdose Manifestations and When to Seek Help

Overdose of Alerzin (Cetirizine/Levocetirizine) is officially documented to primarily affect the Central Nervous System (CNS). Manifestations documented in regulatory labeling include marked CNS depression signs such as somnolence, fatigue, dizziness, confusion, and headache. Other documented clinical signs that require attention include tachycardia (fast heart rate), tremor, and urinary retention.

Required Emergency Actions

Official regulatory guidance uniformly mandates that individuals must seek immediate medical attention and contact a Poison Control Center immediately following any overdose. This requirement is necessary because no specific antidote is known for the active component, and the severe outcomes require professional assessment. Treatment is strictly defined as symptomatic and supportive treatment. Regulatory documents also note that procedures such as gastric lavage may be considered in the clinical management setting, but the active ingredient is not effectively removed by dialysis.

Population-Specific Notes

The clinical presentation can differ based on age. While adults typically present with prominent drowsiness, official labeling for the active component notes that children may initially exhibit agitation and restlessness which is subsequently followed by the onset of somnolence.

Therapeutic Uses of Alerzin

Quick Facts: Alerzin Uses

Therapeutic Domain
Relief of symptoms associated with seasonal allergic rhinitis.
Relief of symptoms associated with perennial allergic rhinitis.
Management of uncomplicated skin manifestations of chronic idiopathic urticaria (chronic hives).

Alerzin (which contains levocetirizine) is a medication utilized in the management of various allergic conditions. Its main purpose is to help provide relief from discomfort and symptoms associated with both seasonal and year-round allergic rhinitis, commonly known as hay fever or upper respiratory allergies.

In the context of seasonal allergies, Alerzin may assist in alleviating symptoms such as a runny nose, sneezing, and irritation of the eyes, nose, or throat. For perennial allergic rhinitis, which occurs throughout the year, the medication may similarly help manage the persistent symptoms.

Additionally, Alerzin is indicated for the treatment of uncomplicated skin manifestations of chronic idiopathic urticaria, which is characterized by the presence of persistent hives without a known external cause.

Eligibility and Restrictions for Use

Alerzin (cetirizine) is an antihistamine whose eligibility for use is determined by age, medical conditions, and physiological state.

Contraindicated Populations

The medicine is contraindicated (must not be used) for individuals with a known hypersensitivity to cetirizine, its parent compound hydroxyzine, or any piperazine derivatives. It is also prohibited for patients with severe renal impairment (creatinine clearance less than 10 mL/min or End-Stage Renal Disease). Patients with rare, hereditary disorders like galactose intolerance should not take the tablet formulation due to excipients.

Eligibility by Age and Condition

  • Children: Use of the standard tablet form is not recommended for children under six years old. The product is generally not recommended for infants and toddlers under two years of age.
  • Renal/Hepatic Impairment: Use is restricted in individuals with moderate to severe kidney impairment, requiring a reduced dosage. While dose adjustment may not be needed for isolated liver impairment, caution is still advised.
  • Pregnancy and Lactation: Use is generally not recommended during lactation, as cetirizine is excreted in breast milk. Pregnant individuals should avoid use unless clearly necessary, based on professional guidance. Special caution is also advised for patients with predisposing factors for urinary retention or those with epilepsy or risk of convulsions.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documentation structures Alerzin's interaction profile around two primary categories: pharmacokinetic clearance and pharmacodynamic effects. There are no specific drug-drug combinations formally listed as contraindicated in the regulatory labels.

Documented Pharmacokinetic Effects

  • Co-administration with Theophylline (at a 400 mg once-daily dose) results in a pharmacokinetic interaction that causes a documented 16% decrease in the clearance of cetirizine, increasing systemic exposure.
  • Studies show no clinically significant pharmacokinetic interaction with medicines such as Pseudoephedrine or Azithromycin.
  • Food intake does not reduce the extent of absorption (total systemic exposure), but it is documented to decrease the rate of absorption.

Documented Pharmacodynamic Effects and Restrictions

  • Alcohol and Other CNS Depressants (Central Nervous System Depressants) may have an additive pharmacodynamic effect. Concurrent use may cause additional reductions in alertness and further impairment of performance.
  • No mandatory timing separation rules for administration are specified in official regulatory text for co-administered substances.

Population-Specific Clearance Notes

  • Patients with renal or hepatic impairment exhibit documented decreases in clearance and increases in half-life compared to healthy subjects. These population-dependent changes significantly modify the drug’s systemic exposure.

Mechanism of Action

Selective Antagonism of Peripheral H1 Receptors

This core mechanism is defined by the selective, high-affinity blockade of H1 receptors located outside the central nervous system. By occupying these receptors, the molecule prevents the natural mediator histamine from initiating its signaling cascade. This action modifies the early molecular steps that govern vascular responses, limiting histamine-induced capillary leakage and vasodilation, which results in the modulation of peripheral tissue fluid dynamics.

Modulation of Inflammatory Cell Recruitment

Beyond direct receptor blockade, the drug engages a separate mechanism that modulates the late-phase allergic pathway. This involves inhibiting the chemotaxis (directed migration) of inflammatory leukocytes, primarily eosinophils, to target tissues. This targeted cellular effect limits the downstream impact of prolonged cellular activation, influencing the dynamics within the inflammatory pathways and shaping the overall effect of the mechanism on inflammation.

Dosage and Administration Information

How Alerzin is Used

Proper use of Alerzin (Cetirizine Hydrochloride) is based on specific administration guidelines to ensure appropriate systemic management of allergic symptoms. The administration protocol is standardized across approved dosage forms and patient populations.


Official Routes and Forms of Administration

Attribute Description
Route of Administration Primarily oral (swallowed).
Available Forms Film-coated tablets, oral drops, and oral solution (syrup).
Intake Condition Can be taken with or without food.
Procedural Note Tablets should be swallowed whole with a glass of liquid.

Standard Dosing Regimens and Frequency

The standard approach involves a once-daily schedule, which is based on the drug's properties. The standard doses are as follows:

  • Adults and Adolescents (12 years and older): The standard and maximum recommended dose is 10 mg once daily.
  • Children (6 to 11 years): The labeled dose is generally 5 mg to 10 mg daily, often administered as 5 mg once daily or 5 mg twice daily, depending on the specific product license.
  • Children (2 to 5 years): The dose is reduced, typically between 2.5 mg and 5 mg daily, usually administered via the oral solution or drops.

Population-Specific Dosing Rules

Dose adjustments are required in certain patient groups to prevent accumulation. For patients with moderate or severe renal impairment, the dose must be reduced to 5 mg once daily. Dose modification is also recommended for older adults if their renal function is reduced. The film-coated tablets are not suitable for children under six years due to the inability to accurately achieve the required lower doses.

Recent Clinical Evidence

Research evidence / Overview of studies for Alerzin (Cetirizine)


Evidence for Use in Seasonal Allergic Rhinitis (SAR)

Research examining the use of Alerzin for conditions characterized by fluctuating or episodic manifestations like seasonal allergic rhinitis primarily relies on short-term, randomized controlled trials (RCTs). These studies were applied in research exploring how symptoms change over a defined time interval, typically ranging from one to six weeks. Researchers in these trials monitored patient-reported outcomes describing perceived discomfort, such as sneezing, itching of the nose and eyes, and runny nose, which are outcomes related to inflammatory or irritative states.

However, the long-term effects are not fully established because the main efficacy trials focused on short-term relief. There is limited information for long-term outcomes regarding sustained patterns related to symptoms. Furthermore, the results apply only to the populations studied, which may not fully represent all degrees of symptom severity encountered in daily life.


Evidence for Use in Perennial Allergic Rhinitis (PAR)

For perennial allergic rhinitis, which involves year-round symptoms, the evidence was evaluated in controlled clinical trials and comparative studies. This research examined outcomes related to physical discomfort and systemic or functional imbalance, such as persistent nasal congestion, post-nasal drip, and itching. Studies were conducted during periods of increased symptom activity and research explored short-term symptom changes in adult and pediatric groups.

A significant research limitation is that follow-up durations were limited, typically lasting only a few weeks. Long-term effects are not fully established, and there is limited information on the sustained symptom patterns over many months. The evidence for some younger children is based on pharmacokinetic extrapolation from older age groups, and direct trial data for this population remains limited.


Evidence for Use in Chronic Idiopathic Urticaria (CIU)

Research for chronic idiopathic urticaria, or chronic hives, involves controlled clinical trials and sometimes specialized crossover studies. The main outcomes related to physical discomfort that were measured included the frequency, size, and severity of wheals (hives) and the intensity of pruritus (itching). Research examined temporary physiological imbalance in the skin, and studies monitored responses over defined time intervals.

The published literature includes descriptions of studies involving dose escalation, which reported outcomes for patient groups experiencing persistent symptoms despite standard use. Findings from these dose-escalation studies are often based on smaller, specialized patient cohorts, which may limit the generalizability of those observed outcomes.

Key Studies & References

  1. Cetirizine: Package Insert / Prescribing Information (General FDA/DailyMed Label)

Frequently Asked Questions (FAQ)

Common questions about Alerzin (FAQ)


Q: What is the main difference between Alerzin and other common allergy medicines?

A: Alerzin is officially classified as a second-generation antihistamine. Official documents describe that it works by selectively targeting and inhibiting peripheral H1 receptors. This specific mechanism of action is often associated with a lower potential for sedation compared to older, first-generation antihistamines.


Q: How quickly does Alerzin usually start working?

A: Regulatory studies indicate that the onset of activity for inhibiting histamine-induced skin responses may occur rapidly, often observed within one hour in most subjects studied. The action involves modifying the early molecular steps that govern vascular responses.


Q: How long do the effects of Alerzin last?

A: The antihistaminic activity following a single dose of Alerzin is documented in studies to persist for at least 24 hours. This duration is related to the drug's elimination, as its half-life (the time it takes for half the drug to be cleared from the body) is approximately 8.3 hours in adults.


Q: Does Alerzin interact with caffeine?

A: Official documentation does not list a specific interaction study with caffeine. However, the label advises caution against concurrent use of Alerzin with any substance that acts as a Central Nervous System (CNS) depressant because it may lead to an additional reduction in alertness or general impairment of performance.


Q: Can I take Alerzin if I am taking other medications for a cold?

A: The official label provides specific pharmacokinetic data for certain ingredients sometimes found in cold remedies, such as pseudoephedrine and azithromycin, showing no clinically significant interaction. However, because 'cold medications' can contain many different active ingredients, the official label does not cover every possible combination.


Q: What happens if I forget to take a dose of Alerzin?

A: Official guidance suggests that if a dose is missed, it may be taken as soon as it is remembered. If the time for the next scheduled dose is near, the official guidance suggests skipping the missed dose to avoid taking more than the prescribed amount.


Q: Does Alerzin help with non-allergy related rashes?

A: The drug is officially indicated for the management of symptoms caused by allergic reactions and hypersensitivity, such as allergic rhinitis and chronic idiopathic urticaria (hives). Its established action is defined by blocking the body's response to histamine released during allergic processes.


Q: Is Alerzin safe for long-term use?

A: Regulatory information does not specify a maximum duration for continuous use. However, the official label includes warnings about the potential for symptoms like pruritus (intense itching) or urticaria (hives) that have been reported upon the sudden discontinuation of the drug following long-term use.


Q: Is it normal to feel a bit dizzy when starting Alerzin?

A: The official adverse reaction profile lists dizziness as a less frequent event reported in clinical studies. Somnolence (drowsiness) and fatigue are also listed as common side effects.


Q: Do I need a prescription to get Alerzin?

A: In many regulatory jurisdictions, the active ingredient, cetirizine hydrochloride, is classified as an Over-the-Counter (OTC) drug product. This means it is available for direct purchase without requiring a prescription from a healthcare provider.


Q: Does Alerzin interact with herbal supplements like St. John's Wort?

A: Specific interactions with herbal supplements are generally not listed in the core regulatory labels. Official caution is generally warranted when considering use with supplements, like St. John's Wort, that may also affect the Central Nervous System, due to the potential for increased side effects such as drowsiness.


Q: Does Alerzin have any effect on blood pressure?

A: Official clinical studies have established that the drug is generally considered to be devoid of cardiac toxicity and is not associated with significant changes in heart function. The drug is not typically listed among those that are known to significantly affect blood pressure.


Q: Is there a generic version of Alerzin available?

A: Yes, the active ingredient, cetirizine hydrochloride, is a widely available compound. Many regulatory agencies, such as the FDA, have approved multiple generic equivalents of this drug that are available in various forms and strengths.


Q: Does taking Alerzin at a certain time of day make a difference?

A: The standard dosing regimen for adults and adolescents is a once-daily schedule. For certain pediatric groups, the label indicates the dose may be divided and administered every 12 hours.


Q: Are there any known differences in how Alerzin affects men versus women?

A: Official regulatory pharmacokinetics data addresses the question of gender differences. The information states that the effect of gender on the drug's pharmacokinetics (how the body absorbs and processes the drug) has not been adequately studied.


Q: Can Alerzin be taken with painkillers like ibuprofen?

A: The core regulatory label does not list a specific interaction with common Nonsteroidal Anti-inflammatory Drugs (NSAIDs) such as ibuprofen. Due to the drug's low level of metabolism by the liver, a clinically significant pharmacokinetic interaction is generally not expected.


Q: What is the purpose of the 'inactive ingredients' listed for Alerzin?

A: Inactive ingredients are components added to the medication that do not have a direct therapeutic effect themselves. They serve important functions, such as providing bulk, helping to stabilize the active ingredient, ensuring proper tablet structure, or aiding in the product's color and dissolution.


Q: Can Alerzin be used for pet allergies?

A: The drug is indicated for symptoms caused by seasonal and perennial allergic rhinitis. This covers symptoms triggered by common environmental and indoor allergens, which includes substances like pet dander.


Q: Are there any known food restrictions while taking Alerzin?

A: Official regulatory information confirms that taking the drug with food does not reduce the total amount of the drug absorbed into the body. However, food intake is documented to slightly delay the rate at which the drug reaches its maximum concentration in the bloodstream.


Q: How does Alerzin affect sleep?

A: The drug's safety profile lists somnolence (drowsiness) as a common adverse reaction, which can affect a patient’s sleep-wake cycle. Official documents also describe this drowsy effect as being dose-related.


Q: Is Alerzin primarily used for seasonal or perennial allergies?

A: Regulatory documents confirm that the drug is formally approved and indicated for the management of symptoms associated with both Seasonal Allergic Rhinitis (SAR) (e.g., hay fever) and Perennial Allergic Rhinitis (PAR) (year-round allergies).


Q: What information is available about Alerzin and pregnancy?

A: The official labeling advises that pregnant individuals should avoid use unless clearly necessary and only use the product with guidance from a healthcare professional. Additionally, the drug is known to be excreted in human breast milk.


Q: Do official documents mention any potential for dependence on Alerzin?

A: The official label does not classify the drug as having a dependence or abuse potential. However, it does include post-marketing reports of severe pruritus (itching) and hives upon discontinuation following long-term use.


Q: Why is Alerzin sometimes prescribed for ear conditions?

A: The drug’s mechanism of action involves blocking histamine and inhibiting the recruitment of inflammatory cells. This action helps to manage the allergic inflammation and congestion that can affect the tissues and fluid dynamics of the Eustachian tubes and middle ear space.

How should Alerzin be stored and disposed of?

Alerzin, which contains cetirizine or levocetirizine, must be stored under specific environmental constraints to maintain its stability, as mandated by regulatory labeling.


Storage Requirements

  • Temperature: Store at Controlled Room Temperature, defined as 20 C to 25 C (68 F to 77 F), with permitted excursions up to 30 C.
  • Protection: The oral solution and drops must be protected from light. Tablets require protection from moisture and excessive heat above 40 C.
  • Container: Keep the medication in the original, tightly closed container. Do not use the product if the container seal is broken or missing.
  • Child Safety: The medication must be kept out of the sight and reach of children.

Disposal Instructions

  • Official Procedure: Unused or expired Alerzin must be disposed of according to local regulatory requirements, often through a pharmaceutical take-back scheme.
  • Prohibited Disposal: Do not dispose of this medicine via household waste or wastewater.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Alerzin found in:

A-Z Index: